Novo Nordisk A/SHere is the public summary page for Novo Nordisk A/S. Please login to see the complete information for Novo Nordisk A/S including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Novo Nordisk A/S stacks up relative to its peers. |
| Darwin Score | +4 |
| Ticker | NVO |
| Latest Price | 48.19 USD as of close on 01-Aug-2025 |
| 3 Month price range | 47.07 to 81.05 USD |
| Market Capitalisation | 213.98Bn USD |
| Country | United States of America |
| Region | Europe |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Pharmaceuticals |
| Sub-Industry | Pharmaceuticals |
| Description | Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark. See More ... |
| Company URL | https://www.novonordisk.com |
| See Darwins Full Analysis for Novo Nordisk A/S |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Novo Nordisk A/S. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -15 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +9 |
| Flow | Institutional, Fund and Insider buying and selling. | +2 |
| Models | Forecast models. | +8 |
Alerts
There are 13 live alerts for Novo Nordisk A/S.
- Oversold - The 30 day RSI is +25.1. (Positive)
- Oversold - The 5 month RSI is +11.3. (Positive)
- Oversold - The 15 month RSI is +22.1. (Positive)
- Divergence: Px Down & OBV Up last 65 days. (Positive)
- Divergence: Px Down & OBV Up last 20 days. (Positive)
- High Volume 2x 65dma. (Positive)
- Divergence: Px Down & OBV Up last 10 days. (Positive)
- 5d RSI Oversold. (Negative)
- Divergence: Px Down & 5d RSI Up last 10 days. (Positive)
- 30d RSI Oversold. (Negative)
- Technically Oversold - 14 day RSI less than 30. (Positive)
- 15d RSI Oversold. (Negative)
- High Volume 2x 130dma. (Positive)
Peer Comparison
There are 8 peers of Novo Nordisk A/S.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Bristol-Myers Squibb Co (BMY) | Pharmaceuticals | -13 |
| Eli Lilly and Co (LLY) | Pharmaceuticals | +23 |
| Johnson & Johnson (JNJ) | Pharmaceuticals | +27 |
| Merck & Co Inc (MRK) | Pharmaceuticals | +16 |
| Organon & Co (OGN) | Pharmaceuticals | +6 |
| Pfizer Inc (PFE) | Pharmaceuticals | +6 |
| Prestige Consumer Healthcare Inc (PBH) | Pharmaceuticals | +20 |
| Zoetis Inc (ZTS) | Pharmaceuticals | +6 |
Share 
